HELX | Franklin Genomic Advancements ETF Overview

(Stock Exchange: BATS)

Day's Range	26.85 - 27.24
52 Week Range	23.74 - 33.98
Beta	1.12
Implied Volatility	26.40%
IV Rank	29.17%
Day's Volume	157
Average Volume	2,372
Shares Outstanding	399,074
Inception Date	2020-02-27

Assets	9,699,000
Asset Class	Equity
Expense Ratio	0.50
P/E Ratio	34.93
EPS	0.78
Dividend Yield	0.02%
Dividend Per Share	0.00
Dividend ExDate	N/A
Dividend PayDate	N/A

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

*Chart delayed

Watching at HELX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HELX Technicals page.